Search
for
Sort by
Research 211–240 of 1000+
- Vitamin D and its Analogs in Treatment of Mild to Moderate Alopecia Areata: Systematic Review and Meta-Analysis.
- Efficacy and safety of tofacitinib therapy in Asian patients with severe alopecia areata
- BH08 Evaluating quality-of-life measures for alopecia: a comparative analysis of Dermatology Life Quality Index and Hospital Anxiety and Depression Scale correlations with disease severity
- Synthetic hair reactions and treatment of complications: Case reports
- Advancing Hair Loss Assessment in Alopecia Areata: The Mathematical Case for Centralised, Standardised Imaging
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- Circulating MicroRNA Signatures in Severe Alopecia Areata: Diagnostic Discrimination, Pathway Analysis, and Therapeutic Implications
- Successful treatment of severe diffuse alopecia areata with abrocitinib
- Improvement in health‐related quality of life and symptoms of anxiety and depression in patients with alopecia areata randomized to baricitinib or placebo: Results from two international randomized controlled trials
- Baricitinib: Exploring the Safety Profile for the Treatment of Alopecia Areata
- Treatment Patterns and Unmet Needs in the Management of Alopecia Areata: Results of a Physician’s Survey in the Middle East
- North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations
- Use of intramuscular triamcinolone acetonide in intermediate responders to janus kinase inhibition for alopecia areata: Case report
- Safety and Efficacy of Adalimumab for the Treatment of Severe Alopecia Areata: Case Series of Three Patients
- II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata
- Platelet-rich plasma and topical minoxidil 5% in the treatment of severe alopecia areata: Report of two cases
- Forensic approach in cases of anabolic-androgenic steroid abuse and cardiovascular mortality: insights from autopsy, histopathology, immunohistochemistry and toxicology
- Use of Jak Inhibitors in the Treatment of Alopecia Areata
- Hair regrowth in alopecia areata patients following Stem Cell Educator therapy
- Efficacy and safety of methotrexate in alopecia areata
- Real-world Burden of Disease and Clinical Characteristics of Alopecia Areata Among Adults in Brazil: Results from a Cross-sectional Survey
- Abrocitinib Improved Dupilumab-Resistant Severe Atopic Dermatitis with Comorbid Mild Alopecia Areata in a 12-Year-Old Boy: A Case Report with 1-Year Follow-Up
- Anxiety, depression, and quality of life in children and adults with alopecia areata: A systematic review and meta-analysis
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- Baricitinib for the Treatment of Alopecia Areata
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Correlation between serum granulysin level and clinical activity in patients with alopecia areata before and after tofacitinib therapy
- Alopecia areata: current concepts
- Characteristics and Management of Patients with Alopecia Areata and Selected Comorbid Conditions: Results from a Survey in Five European Countries